Prednicarbat
Generic name
Prednicarbat
Brand name
ATC Code
D07AC18
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Inflammatory dermatoses |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
CORTICOSTEROIDS, PLAIN
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Corticosteroids, weak (group I) | ||
|---|---|---|
| D07AA02 | ||
| Corticosteroids, moderately potent (group II) | ||
|---|---|---|
| D07AB01 | ||
| D07AB02 | ||
| D07AB09 | ||
| Corticosteroids, potent (group III) | ||
|---|---|---|
| D07AC01 | ||
| D07AC03 | ||
| D07AC17 | ||
| D07AC14 | ||
| D07AC13 | ||
| Corticosteroids, very potent (group IV) | ||
|---|---|---|
| D07AD01 | ||
References
- Sanofi-Aventis Deutschland GmbH, SmPC Dermatop® Creme 2,5 mg/g (5752.00.01), 08/2018
- Sanofi-Aventis Deutschland GmbH, SmPC Dermatop® Salbe 2,5 mg/g (5752.00.02), 08/2018
- Sanofi-Aventis Deutschland GmbH, SmPC Dermatop® Fettsalbe 2,5 mg/g (5752.00.00), 08/2018
Changes
Therapeutic Drug Monitoring
Overdose
